Forte Biosciences, Inc.
FB102
vitiligo
Countdown
177days
Phase 1 readout · ~ Dec 31, 2026 estimated
What's at stake
Phase 1 trial results for FB102 in vitiligo are due ~ Dec 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 14h ago
“The alopecia areata phase 1b data readout is expected in 2026.”